Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin
- PMID: 12962298
- DOI: 10.1007/s10143-003-0258-9
Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin
Abstract
This study describes the migration, proliferation, and invasion behaviour of two human glioma cell lines, GaMg and U-87 Mg, grown as multicellular tumour spheroids after 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitor (simvastatin) therapy. Migration and proliferation studies were performed using simvastatin in concentrations of 0.2-30 microg/ml(-1). A coculture system in which tumour spheroids were confronted with foetal rat brain aggregates was used for invasion studies. A dose-dependent growth and migratory inhibitory response to simvastatin treatment was observed. Marked invasion of the glioma spheroids into the brain aggregates could be seen in both treated and nontreated groups. Simvastatin therapy inhibits tumour cell growth and migration, but the invasiveness of the remaining tumour cells seems to be unaffected.
Similar articles
-
Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro.Neurosurg Rev. 2003 Jul;26(3):198-205. doi: 10.1007/s10143-003-0253-1. Epub 2003 Feb 12. Neurosurg Rev. 2003. PMID: 12845549
-
Effects of photodynamic therapy on glioma spheroids.Br J Neurosurg. 1997 Jun;11(3):196-205. doi: 10.1080/02688699746249. Br J Neurosurg. 1997. PMID: 9231006
-
The inhibitory effect of simvastatin on growth in malignant gliomas--with special reference to its local application with fibrin glue spray in vivo.Int J Oncol. 2001 Sep;19(3):525-31. doi: 10.3892/ijo.19.3.525. Int J Oncol. 2001. PMID: 11494031
-
Cholesterol and mevalonic acid modulation in cell metabolism and multiplication.Toxicol Lett. 1992 Dec;64-65 Spec No:1-15. doi: 10.1016/0378-4274(92)90167-i. Toxicol Lett. 1992. PMID: 1471162 Review.
-
Repurposing simvastatin in cancer treatment: an updated review on pharmacological and nanotechnological aspects.Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7377-7393. doi: 10.1007/s00210-024-03151-2. Epub 2024 May 15. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38748226 Review.
Cited by
-
Assessment of FBA Based Gene Essentiality Analysis in Cancer with a Fast Context-Specific Network Reconstruction Method.PLoS One. 2016 May 4;11(5):e0154583. doi: 10.1371/journal.pone.0154583. eCollection 2016. PLoS One. 2016. PMID: 27145226 Free PMC article.
-
Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature.Drugs. 2022 Feb;82(3):293-310. doi: 10.1007/s40265-021-01668-x. Epub 2022 Feb 5. Drugs. 2022. PMID: 35122635
-
Use of statins or NSAIDs and survival of patients with high-grade glioma.PLoS One. 2018 Dec 3;13(12):e0207858. doi: 10.1371/journal.pone.0207858. eCollection 2018. PLoS One. 2018. PMID: 30507932 Free PMC article.
-
Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation.Int J Nanomedicine. 2012;7:2661-71. doi: 10.2147/IJN.S30445. Epub 2012 May 29. Int J Nanomedicine. 2012. PMID: 22679376 Free PMC article.
-
Simvastatin Hydroxy Acid Fails to Attain Sufficient Central Nervous System Tumor Exposure to Achieve a Cytotoxic Effect: Results of a Preclinical Cerebral Microdialysis Study.Drug Metab Dispos. 2016 Apr;44(4):591-4. doi: 10.1124/dmd.115.068445. Epub 2016 Jan 22. Drug Metab Dispos. 2016. PMID: 26802130 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical